Collegium Pharmaceutical Files 8-K on Officer/Director Changes
Ticker: COLL · Form: 8-K · Filed: May 19, 2025 · CIK: 1267565
| Field | Detail |
|---|---|
| Company | Collegium Pharmaceutical, Inc (COLL) |
| Form Type | 8-K |
| Filed Date | May 19, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, officer-changes, director-changes
TL;DR
Collegium Pharma 8-K: Leadership shakeup, new officers/directors elected, and compensation details filed.
AI Summary
On May 15, 2025, Collegium Pharmaceutical, Inc. filed an 8-K report detailing several key events. These include the departure of directors or certain officers, the election of new directors, the appointment of certain officers, and updates on compensatory arrangements for officers. The filing also covers the submission of matters to a vote of security holders and the filing of financial statements and exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in key personnel and governance can introduce uncertainty and signal strategic shifts, warranting closer monitoring.
Key Players & Entities
- Collegium Pharmaceutical, Inc. (company) — Registrant
- May 15, 2025 (date) — Date of earliest event reported
FAQ
Who are the specific directors or officers departing from Collegium Pharmaceutical, Inc.?
The filing does not specify the names of the departing directors or officers, only that such departures have occurred.
Who are the newly elected directors or appointed officers?
The filing indicates the election of directors and appointment of officers but does not name the individuals involved.
What specific matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders but does not detail the specific proposals.
Are there any new compensatory arrangements for certain officers disclosed in this filing?
The filing mentions compensatory arrangements of certain officers as an item of information but does not provide specific details within the provided text.
What financial statements and exhibits are being filed with this 8-K?
The filing indicates that financial statements and exhibits are being filed, but the specific documents are not listed in the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 19, 2025 regarding COLLEGIUM PHARMACEUTICAL, INC (COLL).